BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option(Right to buy)
2022-02-07+416,500→ 1,601,500 totalExercise: $3.78Exp: 2032-02-07→ Common Stock (416,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 7, 2024.